SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-319317
Filing Date
2021-11-04
Accepted
2021-11-04 07:28:02
Documents
5
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 6-K d230045d6k.htm 6-K 24061
2 EX-1.1 d230045dex11.htm EX-1.1 233585
3 EX-5.1 d230045dex51.htm EX-5.1 31542
4 GRAPHIC g230045g1102102721994.jpg GRAPHIC 1313
5 GRAPHIC g230045g1102102722291.jpg GRAPHIC 1798
  Complete submission text file 0001193125-21-319317.txt   294772
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Filer) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39545 | Film No.: 211378008
SIC: 2834 Pharmaceutical Preparations